Sine Health Receives FDA 510(k) Clearance for the First Smartphone Essential Tremor Monitoring Device

Sine measures tremor passively through a patient's own smartphone. It is the company's second FDA clearance since founding last year

STOCKHOLM, Nov. 17, 2026 /PRNewswire/ — Sine Health today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K261026) for Sine, its smartphone-based essential tremor monitoring system.

Sine measures tremor passively as patients go about their day, using the sensors already in their smartphone. Like a step counter, the app works in the background, giving clinicians an objective view of how a patient’s tremor changes between visits. Sine is the first FDA-cleared way to monitor essential tremor using only a smartphone.

Sign up for Blog Updates